Basal Cell Carcinoma: Multimedia

References

1. Bale AE, Yu KP. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet. Apr 2001;10(7):757-62. [Medline].

2. Wicking C, McGlinn E. The role of hedgehog signalling in tumorigenesis. Cancer Lett. Nov 8 2001;173(1):1-7. [Medline].

3. National Center for Biotechnical Information. Tumor Protein p53; TP53. Online Mendelian Inheritance in Man. Available at http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170. Accessed November 7, 2007.

4. Betti R, Radaelli G, Mussino F, Menni S, Crosti C. Anatomic location and histopathologic subtype of basal cell carcinomas in adults younger than 40 or 90 and older: any difference?. Dermatol Surg. Feb 2009;35(2):201-6. [Medline].

5. Griffin JR, Cohen PR, Tschen JA, et al. Basal cell carcinoma in childhood: case report and literature review. J Am Acad Dermatol. Nov 2007;57(5 Suppl):S97-102. [Medline].

6. Klein RD, Dykas DJ, Bale AE. Clinical testing for the nevoid basal cell carcinoma syndrome in a DNA diagnostic laboratory. Genet Med. Nov-Dec 2005;7(9):611-9. [Medline].

7. National Center for Biotechnical Information. Bazex Syndrome; BZX. Online Mendelian Inheritance in Man. Available at http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=301845. Accessed November 7, 2007.

8. Michaëlsson G, Olsson E, Westermark P. The Rombo syndrome: a familial disorder with vermiculate atrophoderma, milia, hypotrichosis, trichoepitheliomas, basal cell carcinomas and peripheral vasodilation with cyanosis. Acta Derm Venereol. 1981;61(6):497-503. [Medline].

9. Karagas MR. Occurrence of cutaneous basal cell and squamous cell malignancies among those with a prior history of skin cancer. The Skin Cancer Prevention Study Group. J Invest Dermatol. Jun 1994;102(6):10S-13S. [Medline].

10. [Guideline] U.S. Preventive Services Task Force. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. Feb 3 2009;150(3):188-93. [Medline].

11. [Guideline] From L, Marrett L, Rosen C, et al. Screening for skin cancer: a clinical practice guideline. National Guidelines Clearinghouse. Jun 2007.

12. [Guideline] Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol. Jul 2008;159(1):35-48. [Medline].

13. Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. J Dermatol Surg Oncol. Sep 1991;17(9):720-6. [Medline].

14. Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol. Jun 1992;18(6):471-6. [Medline].

15. Bennett RG. Current concepts in Mohs micrographic surgery. Dermatol Clin. Oct 1991;9(4):777-88. [Medline].

16. Roenigk RK. Mohs' micrographic surgery. Mayo Clin Proc. Feb 1988;63(2):175-83. [Medline].

17. Ducic Y, Marra DE, Kennard C. Initial Mohs surgery followed by planned surgical resection of massive cutaneous carcinomas of the head and neck. Laryngoscope. Apr 2009;119(4):774-7. [Medline].

18. Silverman MK, Kopf AW, Gladstein AH, Bart RS, Grin CM, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol. Jul 1992;18(7):549-54. [Medline].

19. Aldara cream 5% (imiquimod) [package insert]. Graceway Pharmaceuticals; 2007.

20. Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol. May 2004;50(5):722-33. [Medline].

21. Sapijaszko MJ. Imiquimod 5% cream (Aldara) in the treatment of basal cell carcinoma. Skin Therapy Lett. Jul-Aug 2005;10(6):2-5. [Medline]. [Full Text].

22. Micali M, Nasca MR, Musumeci ML. Treatment of an extensive superficial basal cell carcinoma of the face with imiquimod 5% cream. Int J Tissue React. 2005;27(3):111-4. [Medline].

23. Bilu D, Sauder DN. Imiquimod: modes of action. Br J Dermatol. Nov 2003;149 Suppl 66:5-8. [Medline].

24. Wuest M, Dummer R, Urosevic M. Induction of the members of Notch pathway in superficial basal cell carcinomas treated with imiquimod. Arch Dermatol Res. Dec 2007;299(10):493-8. [Medline].

25. Efudex (fluorouracil) [package insert]. Valeant Pharmaceuticals; 2005.

26. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. Jan 2007;56(1):125-43. [Medline].

27. Mosterd K, Thissen MR, Nelemans P, et al. Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial. Br J Dermatol. Sep 2008;159(4):864-70. [Medline].

28. Rhodes LE, de Rie MA, Leifsdottir R, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol. Sep 2007;143(9):1131-6. [Medline].

29. Rhodes LE, de Rie MA, Leifsdottir R, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol. Sep 2007;143(9):1131-6. [Medline].

30. [Guideline] Morton CA, McKenna KE, Rhodes LE, et al. Guidelines for topical photodynamic therapy: update. Br J Dermatol. Dec 2008;159(6):1245-66. [Medline].

31. Brodland DG. Diagnosis of nonmelanoma skin cancer. Clin Dermatol. Nov-Dec 1995;13(6):551-7. [Medline].

32. Frankel DH, Hanusa BH, Zitelli JA. New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up. J Am Acad Dermatol. May 1992;26(5 Pt 1):720-6. [Medline].

33. Fritsch P. Dermatologie und Venerologie. 2^nd ed. Berlin, Germany: Springer; 2004.

34. Goldman L, Gregory RO, La Plant M. Preliminary investigative studies with PDT in dermatologic and plastic surgery. Lasers Surg Med. 1985;5(5):453-6. [Medline].

35. Kirkham N. Tumors and cysts of the epidermis. In: Elder D, Elenitas R, Jaworsky C, Johnson B, eds. Lever's Histopathology of the Skin. 8^th ed. Philadelphia, Pa: Lippincott-Raven; 1997:719-46.

36. Lang PG, Maize JC. Basal cell carcinoma. In: Friedman RJ, Rigel, Kopf AW, Harris MN, Baker D, eds. Cancer of the Skin. Philadelphia, Pa: WB Saunders; 1991:35-73.

37. Lowe L. Histology: basal cell carcinoma. In: Maloney ME, Miller SJ, eds. Cutaneous Oncology. Oxford, England: Blackwell Science; 1998:633-45.

38. Maloney ME, Miller SJ. Aggressive versus nonaggressive subtypes: basal cell carcinoma. In: Maloney ME, Miller SJ, eds. Cutaneous Oncology. Oxford, England: Blackwell Science; 1998:609-13.

39. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. May 1994;30(5 Pt 1):774-8. [Medline].

40. Miller SJ. Pathogenesis: basal cell carcinoma. In: Maloney ME, Miller SJ, eds. Cutaneous Oncology. Oxford, England: Blackwell Science; 1998:581-5.

41. Nguyen TH, Ho DQ. Nonmelanoma skin cancer. Curr Treat Options Oncol. Jun 2002;3(3):193-203. [Medline].

42. Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer. Dec 2003;3(12):903-11. [Medline].

43. Poniecka AW, Alexis JB. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol. Aug 1999;21(4):332-6. [Medline].

44. Ponten F, Lundeberg J. Principles of Tumor Biology and Pathogensesis of BCCs and SCCs. In: Bolognia JL, et al, eds. Dermatology. Vol 2. ed. China: Mosby; 2004:1663-76.

45. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med. Dec 3 1992;327(23):1649-62. [Medline].

46. Ratner D, Skouge JW. Surgical management of local disease: basal cell carcinoma. In: Maloney ME, Miller SJ, eds. Cutaneous Oncology. Oxford, England: Blackwell Science; 1998:664-71.

47. Robinson JK. What are adequate treatment and follow-up care for nonmelanoma cutaneous cancer?. Arch Dermatol. Mar 1987;123(3):331-3. [Medline].

48. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. Nov 24 2005;353(21):2262-9. [Medline].

49. Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 1: Overview. J Dermatol Surg Oncol. Sep 1991;17(9):713-8. [Medline].

50. Tope WD, Shaffer JJ. Photodynamic Therapy. In: Bolognia JL, et al, eds. Dermatology. Vol 2. ed. China: Mosby; 2004:2127-40.

51. Tromovitch TA, Stegeman SJ. Microscopically controlled excision of skin tumors. Arch Dermatol. Aug 1974;110(2):231-2. [Medline].

Further Reading

Keywords

basal cell carcinoma, basal cell epithelioma, BCC, nodular basal cell carcinoma, nodular BCC, skin cancer, skin carcinoma, sun exposure, UV exposure, sunburn, sun burn, ultraviolet light exposure, UV light exposure, skin malignancy, arsenic exposure, xeroderma pigmentosum

nevoid BCC syndrome, basal cell nevus syndrome, Gorlin syndrome, Bazex syndrome, Rombo syndrome

Contributor Information and Disclosures

Author

Michael L Ramsey, MD, Director, Mohs Surgery Fellowship, Co-Director, Procedural Dermatology Fellowship, Department of Dermatology, Geisinger Medical Center
Michael L Ramsey, MD is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Micrographic Surgery and Cutaneous Oncology, and American Society for Dermatologic Surgery
Disclosure: Nothing to disclose.

Coauthor(s)

Lindsay Dane Sewell, MD, Staff Physician, Department of Dermatology, Geisinger Medical Center
Lindsay Dane Sewell, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Medical Editor

R Stan Taylor, MD, Professor of Dermatology, University of Texas Southwestern Medical School; Director of Skin Surgery and Oncology Clinic, Department of Dermatology, University of Texas Southwestern Medical Center
R Stan Taylor, MD is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Surgery, American Dermatological Association, American Medical Association, American Society for Dermatologic Surgery, Christian Medical & Dental Society, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Edward F Chan, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine
Edward F Chan, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

CME Editor

Catherine M Quirk, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania
Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.